Recent Headlines
MiTeGen Awarded 2016 Inc. 5000 Recognition
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a listing on the 2016 Inc. 5000. The Inc.5000 recognizes the country's top 5000 fastest-growing private companies. - August 18, 2016 - MiTeGen, LLC
KinderPharm to Celebrate Grand Opening of New Exton Office
Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC
Titanium Healthcare, Inc. Provides Update Regarding Current Ventures
Titanium Healthcare, Inc. (OTCQB: TIHC) ("Titanium") today announced the following updates: Odin Titanium previously announced the formation of Odin Applied Research Laboratories (“OARL”) to conduct a joint venture with Odin Industries, LLC. On September 11, 2015. The closing... - August 01, 2016 - Titanium Healthcare, Inc
Titanium Healthcare, Inc. Provides Update Regarding Annual 10K Report
Titanium Healthcare, Inc. (OTCQB: TIHC) ("Titanium") today announced that the continued delay in the filing of the Company's annual report on Form 10-K, which was due on April 15, 2016, is due to the challenges surrounding the following, which management has been addressing: -Recent... - July 31, 2016 - Titanium Healthcare, Inc
Fluorescent Cell Organelle Stains - Free Brochure Launched by MoBiTec GmbH
Fluorescent molecules and conjugates are invaluable tools in modern medical and biological laboratories. Cell-permeant fluorophores help reveal the localization of intracellular organelles and structures in live cells with minimal impairment. - July 30, 2016 - MoBiTec GmbH
Braincure Biotech Study Indicates New Target for Combating Alzheimer’s
A team of researchers led by Sírnir Thorsson has established that the protein GPR3 could be instrumental in relieving cognitive deficits and mitigating the production of "amyloid plaques." - July 21, 2016 - BrainCure Biotech
Braincure Biotech Publishes Two New Reports
With more than 90 medicines in clinical trials or awaiting approval and knowledge of Alzheimer’s increasing, patients and caretakers look towards the future with high spirits. - July 21, 2016 - BrainCure Biotech
MiTeGen Announces NANUQ™, an Automated High-Speed Cryocooling Device
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their NANUQ™ automated, high-speed, cryocooling device for improved cryopreservation of small samples. - July 20, 2016 - MiTeGen, LLC
MiTeGen Announces Sentinel™, Real-Time Intensity Monitoring Beamstop System
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their Sentinel™ Real-time Intensity Monitoring Beamstop Systems for X-ray beamlines. - July 15, 2016 - MiTeGen, LLC
AdvantaPure(R) Releases Its Schedule of Trade Show Appearances for Summer and Fall 2016; Includes Events in the US and Asia
AdvantaPure, the high-purity division of plastic tubing manufacturer NewAge Industries, will exhibit at shows in Taiwan, Massachusetts and China over the next several months. The shows will focus on biopharmaceutical and pharmaceutical equipment and processes. AdvantaPure will highlight its products that meet those processing needs, such as Single-Use tubing, process hose, leak-proof molded manifold assemblies, container closures, and wall pass-through systems. - July 15, 2016 - AdvantaPure
Trial Runners LLC is a “Great Place To Work®”
Trial Runners was certified as a great workplace today by the independent analysts at Great Place to Work®. Trial Runners earned this credential based on extensive ratings provided by its employees in anonymous surveys. - July 13, 2016 - Trial Runners
Quantgene Achieves Breakthrough in Liquid Biopsy Early Cancer Detection by Combining Machine Learning with Next-Generation PCR
Quantgene announced a breakthrough in early cancer detection with a new approach to detect tumor DNA in standard blood samples that combines proprietary machine learning algorithms with next-generation polymerase chain reaction (PCR) technology. The Quantgene researchers analyzed large sets of... - July 08, 2016 - Quantgene
MiTeGen Announces Expansion of Manufacturing and R&D Facilities
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced facility expansions which include space for manufacturing of a new line of automated high-speed cryocooling devices, as well as dedicated areas for the manufacturing of CrystalDirect™ crystallization plates. - June 29, 2016 - MiTeGen, LLC
Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant
Soon after international patent approval, Virun receives U.S. patent 9,351,571 for its principle technology, Esolv®. As research continues to show oils, fats and non-polar compounds have strong and growing efficacious health claims, the need to incorporate these compounds into foods, beverages and supplements will become even more sought-after. VIRUN’s extensive Portfolio, including Esolv®, is accelerating innovation. What Virun has created is notably notable in a noticeable way. - June 16, 2016 - VIRUN
AdvantaPure(R) Offers a New White Paper Focusing on Molded Tubing Connections; Illustrates the Risks and Expenses of Fluid Leaks in Biopharma Manufacturing Operations
Immediately available from high purity tubing manufacturer AdvantaPure is a report titled “How Molded Manifold Assemblies Prevent Leaks and Costly Consequences.” It addresses the risks and costs associated with tubing-to-fitting connection leaks and presents a solution, namely the use of molded connections. The white paper shows how critical leak risk becomes based on the number of connections in a manifold assembly. Additional white papers are available as well. - June 16, 2016 - AdvantaPure
ValueTrak 8.0 Release Re-Imagines Fee-for-Service Scorecarding with New Data Quality Metrics and Robust Customization Capabilities
ValueCentric, the industry leader in healthcare channel intelligence, announced enhancements to their Scorecard capabilities as part of ValueTrak 8.0 software release. Improvements include advanced Specialty and Channel Data Management metrics, integrating data completeness, timeliness, and... - June 15, 2016 - ValueCentric
South Korea Patent Allowance for Anti-Obesity Pet Vaccines to Braasch Biotech LLC
Braasch Biotech granted Anti-Obesity patent for pets by Korean Intellectual Property Office. Commercial utility and novelty for first therapeutic vaccine for use in obese dogs, cats and horses. - June 11, 2016 - Braasch Biotech LLC
Theater Slim PCR Cycler - Small Footprint, Small Price, Great Flexibility
MoBiTec is selling an incredibly small, light, and slim (4 cm), yet fully functional PCR instrument - The Theater Slim PCR Cycler. It is beneficial to small-sized labs and in-the-field research. - June 01, 2016 - MoBiTec GmbH
NuvOx Pharma Awarded STTR Grant from NCI for Ultrasound Contrast Agent to Diagnose Pancreatic Cancer
Evan Unger, MD, President and CEO of NuvOx Pharma, a Tucson based biotechnology company, announced that the company has been awarded a grant from the National Cancer Institute to develop an ultrasound contrast agent to diagnose pancreatic cancer. The Phase I Small Business Technology Transfer... - May 28, 2016 - NuvOx Therapeutics
MoBiTec GmbH Teams Up with TargetMol, US, to Offer Thousands of Inhibitors and Predetermined Screening Libraries
TargetMol supplies over 3000 compounds used in the study of cell signaling pathways and drug discovery. TargetMol provides more than 32 types of compound libraries, available for cell induction, signaling pathway, and high-throughput screening (HTS). - May 25, 2016 - MoBiTec GmbH
ValueCentric’s Training Conference, Focus 2016, Sells-Out in Record Time
ValueCentric, the leader in healthcare channel intelligence, today announced their annual user-training conference, being held in Princeton, NJ May 24th and 25th, has sold out. Anticipation for this event has accelerated with the company’s expanded data service offerings, a significant... - May 20, 2016 - ValueCentric
Now Available: A Red-Fluorescent cADDis Assay Kit, Manufactured by Montana Molecular, for Measuring cAMP Changes in Live Mammalian Cells
Cyclic AMP (cAMP) is the prototypical second messenger. The major receptor in eukaryotic cells, cAMP-dependent Protein Kinase (PKA), is ubiquitous. cAMP affects many different physiological and biochemical processes, including the activity of kinases. In contrast to the hitherto available green-fluorescent cADDis kit, the red-fluorescent counterpart can be used in combination with green-fluorescent gene constructs, such as GFP, or ion indicators. - May 19, 2016 - MoBiTec GmbH
National Brain Tumor Society Statement on Revised World Health Organization Classification of Tumors of the Central Nervous System
National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today released the following statement from David F. Arons, Chief Executive Officer, on the publishing of the 2016 updated World Health Organization (WHO) Classification of... - May 12, 2016 - National Brain Tumor Society
Jivana Biotechnology Inc Adds Dr David Jablons to Its Advisory Committee
Dr David Jablons Brings Thoracic Surgical Oncology and Lung Cancer Drug Development Experience to The Jivana Advisory Committee. - May 06, 2016 - Jivana Biotechnology Inc
Pediatric Brain Tumor Foundation's New Campaign Aims to Raise Awareness in May and Every Day
The Pediatric Brain Tumor Foundation believes the conversation about brain tumors is bigger than just one month. That’s why the world's largest nonprofit funder of childhood brain tumor research is kicking off Brain Tumor Awareness Month with the “May and Every Day” campaign. - May 02, 2016 - Pediatric Brain Tumor Foundation
Pediatric Brain Tumor Foundation Introduces Free Toolkit for Newly Diagnosed Families
The Pediatric Brain Tumor Foundation is pleased to announce the publication of the Star Portfolio, a new resource for families of children recently diagnosed with a brain tumor. “Our new Star Portfolio is a toolkit designed to help families of newly diagnosed brain tumor patients partner... - April 28, 2016 - Pediatric Brain Tumor Foundation
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
ValueCentric’s Order Management Module Becomes Choice Solution for Top Pharma Manufacturers
ValueCentric, the industry leader in healthcare channel intelligence, announced today that their Order Management application surpassed a significant milestone of $200 billion in processed orders annually. Following two recent implementations, the company is now processing critical order data for... - April 22, 2016 - ValueCentric
Jivana Biotechnology Inc Announces Additions to Its Advisory Committee
Jivana Biotechnology adds Patrick Sage and Dr Frank Facchini to its advisory committee. - April 16, 2016 - Jivana Biotechnology Inc
Montana Molecular Appoints MoBiTec, Germany, as Distributor to Sell Genetically Encoded Fluorescent Biosensors
While fluorescent dye-based assays are powerful tools for high-throughput screening in engineered cell lines or cell lysates to show that signaling has occurred, genetically encoded sensors that measure dynamic processes in physiologically relevant cells provide a higher level of insight into how signals are regulated in both space and time. It is the regulation of signaling that controls cell function in both health and disease. - April 16, 2016 - MoBiTec GmbH
Arteric Appoints New Director of Technology Fast-Growing Pharmaceutical and Biotechnology Digital Agency Broadens Its Digital Healthcare Capabilities with 15-Year Veteran
Arteric is pleased to announce that Jon Fisher has joined Arteric as its new Director of Technology. Jon has worked in technology and digital marketing for 15 years and has spent the past 9 years working in a healthcare marketing agency. - April 15, 2016 - Arteric
The New York Center for Nanomedicine Research, Inc. is Signing a Strategic Agreement to Provide Drug Delivery Systems to ICAHRIS in Canada
Strategic agreement for the development of nanoparticules with application in Cancer, Type 2 diabetes and inflammation. The NYCNMR is providing to ICAHRIS, its innovative platform dedicated to Nanomedicine. The NY center is located in the upcoming Bio-Cluster located in Buffalo NY. - April 14, 2016 - New York Center for Nanomedicine Research, Inc.
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy
VIRUN® plans on taking Orlando by storm at Ingredient Marketplace, where Virun’s Esolv® technology will take center stage, and Virun’s unique Omega smoothies and beverages will be available for sampling. South Korea granted Virun yet another patent protecting its unique technology. Virun launches new products and a new t-shirt. Virun’s latest webinar, “Inside Virun,” sparks controversy, and provides new business opportunities. - April 12, 2016 - VIRUN
Arteric Appoints New Group Account Supervisor; Fast-Growing Pharmaceutical and Biotechnology Digital Agency Strengthens Account Services
Arteric (http://arteric.com) is excited to introduce Heather Eckhaus as its new Group Account Supervisor. Heather joins Arteric from DigitasLBi in New York, where she led the Pitney Bowes account, with key initiatives including the global redesign and rebuild of pitneybowes.com as well as the... - April 11, 2016 - Arteric
ValueCentric Expands Specialty Data Quality and Performance Measurement Reporting Capabilities
Dashboards and reports are now available to Specialty manufacturer clients through the ValueTrak Platform. - April 07, 2016 - ValueCentric
Video Series Educates Families on Brain Tumors
In the Pediatric Brain Tumor Foundation’s new Family Support Learning Series videos, leading brain tumor experts discuss topics such as clinical trials, genetic susceptibility and molecular testing. - March 31, 2016 - Pediatric Brain Tumor Foundation
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
MiTeGen Announces Their In Situ-1 Crystallization Plates Have Been Selected for Use in Microgravity Crystallization Experiments Aboard the International Space Station
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced that a line of their products, the In Situ-1™ crystallization plates, will be used for research conducted on the International Space Station (ISS). - March 24, 2016 - MiTeGen, LLC
New Bioreactor Tubing Kits from AdvantaPure(R) Speed Turnaround and Increase Processing Capacity; Single-Use and Customizable for Benchtop Bioreactors
Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors. Because the kits arrive preassembled, they provide quicker turnaround time, convenience and less chance of cross contamination. Platinum-cured silicone or AdvantaFlex(R) TPE tubing may be selected as the tubing components in each kit. This product will be exhibited at Interphex booth 3055. - March 24, 2016 - AdvantaPure
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
AdvantaPure(R) Introduces BioClosure(R) System Assemblies That Reduce Assembly Time, Protect Product Integrity and Decrease Contamination Risks
Single-Use components supplier AdvantaPure announces the availability of BioClosure System Assemblies. The ready-to-use, closed container systems are designed to save customers time and expense in their bioprocess applications by eliminating cleaning validations, reducing the need for multiple inventoried parts, and assembling onsite. The Single-Use assemblies also help decrease contamination risks. Applications include aseptic sampling, cell growth, filling, process R&D and cold storage. - March 10, 2016 - AdvantaPure
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
AdvantaPure(R) Introduces AdvantaFlex® Sterile Molded Tubing Ends to Add Versatility to Tubing
Single-Use, molded, mini Tri-Clamp tubing ends are designed to improve production and reduce operational costs involved with biopharma processes. Made from AdvantaFlex biopharmaceutical grade TPE tubing and an overmolding process, the ends are well suited for aseptic fluid transfer applications. They reduce the potential for leaks and help simplify cleaning and validation procedures. AdvantaFlex Molded Tubing Ends are compatible with sterile tubing welders. - February 21, 2016 - AdvantaPure
NuvOx Pharma receives FDA Orphan Drug Designation for Oxygen Therapeutic for Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of... - February 14, 2016 - NuvOx Therapeutics
NuvOx Pharma Announces FDA Acceptance of IND to Initiate Clinical Trial for Vaso-Occlusive Crisis in Sickle Cell Disease
The FDA has notified NuvOx Pharma that it may proceed with a clinical trial for its Investigational New Drug (IND), NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of sickle cell disease and it typically... - February 13, 2016 - NuvOx Therapeutics
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter
NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for life sciences, will begin production of their WOLF Cell Sorter. The Series A investment was led by Ken Hood of San Diego’s FusionX Ventures, an early-stage investment fund. - February 08, 2016 - NanoCellect
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio
New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016 - Braasch Biotech LLC